A product from Merck designated as MK-0524, also known as Laropiprant, is to be trialled as a treatment for the redness of rosacea. This is great news for rosacea …
October 14th, 2011, by David Pascoe | clinical trials, new treatments, red face
A product from Merck designated as MK-0524, also known as Laropiprant, is to be trialled as a treatment for the redness of rosacea. This is great news for rosacea …
May 20th, 2011, by David Pascoe | red face, steroids
Steroid Induced Rosacea is, sadly, one hot topic.
I know this because the blog posting Treating Steroid Induced Rosacea is one of the most visited pages on this site, and is currently approaching 1000 comments. Unfortunately many …
April 20th, 2011, by David Pascoe | new treatments, oxymetazoline, red face
A Press Release today (Vicept are happy to generate publicity at every step of their development) touting more Phase II Study results for their Oxymetazoline based V-101 product. V-101 is a topical slated to treat the …
March 2nd, 2011, by David Pascoe | new treatments, oxymetazoline, red face
A brief extract today covering a paper detailing how the topical Xylometazoline can be used to treat the redness of rosacea. Similar to oxymetazoline, xylometazoline is marketed as a nasal decongestant under many brand …
January 31st, 2011, by David Pascoe | cutanix, red face
We were tipped off by a comment on the blog posting about Cutanix going offline, to the possible future availability of a Cutanix like product. The commenter, who works for SkinMedica told us that; skincarejunkie Bioform was sold to Merz Aesthetics. In that sale Cutanix was sold to …